Bulletin
Investor Alert

Cardiff Oncology Inc.

NAS: CRDF

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201555650/composite

$

1.73

Change

0.00 0.00%

Volume

Volume 131,100

Mar 20, 2023, 4:19 p.m.

Real time quotes

/zigman2/quotes/201555650/composite

Today's close

$ 1.76

$ 1.73

Change

-0.03 -1.70%

Day low

Day high

$1.60

$1.76

Open
Open: 1.76

52 week low

52 week high

$1.13

$3.41

Open

Market cap

$78.63M

Average volume

245,460

P/E ratio

N/A

Rev. per Employee

$14,846

EPS

-0.89

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crdf

MarketWatch News on CRDF

  1. Cardiff Oncology stock price target cut to $9 from $14 at Maxim Group

    8:35 a.m. Feb. 25, 2022

    - Tomi Kilgore

  2. Cardiff Oncology stock price target cut to $14 from $25 at Maxim Group

    8:47 a.m. Jan. 24, 2022

    - Tomi Kilgore

  3. Cardiff Oncology stock price target raised to $25 from $20 at Maxim Group

    11:36 a.m. Sept. 9, 2021

    - Tomi Kilgore

  4. Cancer Meeting’s High Hopes for Amgen and Gilead

    8:22 a.m. Sept. 21, 2020

    - Barron's Online

  5. TrovaGene shares downgraded to a hold rating from buy at Maxim Group

    8:42 a.m. Nov. 10, 2017

    - Trey Williams

  6. TrovaGene upgraded to buy from hold at Maxim Group

    2:06 p.m. April 12, 2017

    - Tomi Kilgore

  7. David Sokol Sizes Up Middleburg Financial

    12:05 a.m. April 9, 2016

    - Barron's Online

  8. TrovaGene stock price target cut to $8 from $11 at Janney Montgomery Scott

    9:41 a.m. March 11, 2016

    - Tomi Kilgore

  9. TrovaGene downgraded to neutral from buy at Janney Montgomery Scott

    9:41 a.m. March 11, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/crdf

Other News on CRDF

  1. 10-K: CARDIFF ONCOLOGY, INC.

    5:03 p.m. March 2, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Cardiff Oncology (CRDF) Investor Presentation - Slideshow

    12:04 p.m. Nov. 4, 2022

    - Seeking Alpha

  3. 10-Q: CARDIFF ONCOLOGY, INC.

    4:02 p.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. ASTS, ONTX and BITF among pre market gainers

    8:40 a.m. Sept. 12, 2022

    - Seeking Alpha

  5. Cardiff Oncology (CRDF) Investor Presentation - Slideshow

    12:18 p.m. Sept. 9, 2022

    - Seeking Alpha

  6. Cardiff Oncology: Down But Not Out

    7:03 p.m. Aug. 22, 2022

    - Seeking Alpha

  7. 10-Q: CARDIFF ONCOLOGY, INC.

    4:08 p.m. Aug. 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. TAL, CRDF and VIRX among mid-day movers

    12:49 p.m. June 9, 2022

    - Seeking Alpha

  9. Cardiff Oncology: Upcoming Readouts And Several Green Lights

    10:51 a.m. June 7, 2022

    - Seeking Alpha

  10. Cardiff Oncology (CRDF) Investor presentations - Slideshow

    11:50 a.m. May 25, 2022

    - Seeking Alpha

  11. Cardiff Oncology: Risky Investment

    10:09 a.m. May 19, 2022

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/crdf

Press Releases on CRDF

  1. Cardiff Oncology Formally Introduces Scientific Advisory Board

    9:15 a.m. March 6, 2023

    - PR Newswire - PRF

  2. Cardiff Oncology to Present at Upcoming Investor Conferences

    11:53 a.m. Nov. 21, 2022

    - PR Newswire - PRF

  3. Liquid Biopsy Market Share to Witness Steady Rise by 2029

    12:52 a.m. Aug. 4, 2022

    - AmericaNewsHour

  4. Monday Sector Laggards: Entertainment, Biotechnology Stocks

    11:57 a.m. July 11, 2022

    - MarketNewsVideo.com

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.